公开(公告)号：US20130172209A1

公开(公告)日：2013-07-04

申请号：US13739447

申请日：2013-01-11

Applicant: BIOMERIEUX

Inventor： Maud ARSAC ,  Bertrand BONNAUD ,  Francois MALLET ,  Jean-Philippe PICHON

IPC: C12Q1/70

CPC classification number: C12Q1/702 ,  C12Q1/6886 ,  C12Q2600/154 ,  C12Q2600/158

Abstract: The invention relates to a method for in vitro diagnosis or prognosis of testicular cancer which comprises a step of detecting the presence or absence of at least one expression product from at least one nucleic acid sequence selected from the sequences identified in SEQ ID NOS: 1 to 6 or from the sequences which exhibit at least 99% identity with one of the sequences identified in SEQ ID NOS: 1 to 6, to isolated nucleic acid sequences and to the use thereof as a testicular cancer marker.

Abstract translation: 本发明涉及一种用于体外诊断或睾丸癌预后的方法，其包括从至少一种选自SEQ ID NO：1中鉴定的序列的核酸序列检测至少一种表达产物的存在或不存在的步骤， 6或来自与SEQ ID NO：1至6中鉴定的一个序列具有至少99％同一性的序列，或与分离的核酸序列及其作为睾丸癌标志物的用途的序列。